Name: Allergan PLC (NYSE:AGN) | Analysis of Debt
Creator: Stock Analysis on Net

Allergan PLC, balance sheet: debt

US$ in thousands

	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Current portion of long-term debt and capital leases	4,532,500)	868,300)	4,231,800)	2,797,900)	2,432,800)
Long-term debt and capital leases, excluding current portion	18,116,500)	22,929,400)	25,843,500)	29,970,800)	40,293,400)
Total long-term debt and capital leases, including current portion (carrying amount)	22,649,000)	23,797,700)	30,075,300)	32,768,700)	42,726,200)

Download chart

Debt item	Description	The company
Total long-term debt and capital leases, including current portion (carrying amount)	Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations.	Allergan PLC total debt decreased from 2017 to 2018 and from 2018 to 2019.

	Dec 31, 2019
Selected Financial Data (US$ in thousands)
Senior Notes	23,679,100)
Margin Loan	—)
Term Loan Indebtedness	—)
Other borrowings	72,600)
Capital leases	—)
Total long-term debt and capital leases, including current portion (fair value)	23,751,700)
Financial Ratio
Debt, fair value to carrying amount ratio	1.05

Weighted-average interest rate on debt: 3.50%

Interest rate	Debt amount¹	Interest rate × Debt amount
3.00%	2,529,500)	75,885)
3.38%	654,700)	22,096)
4.88%	463,400)	22,591)
5.00%	1,262,900)	63,145)
3.45%	2,945,100)	101,606)
3.25%	1,739,100)	56,521)
2.80%	352,700)	9,876)
3.85%	1,089,900)	41,961)
3.80%	3,172,400)	120,551)
4.55%	1,953,400)	88,880)
4.63%	482,800)	22,330)
4.85%	1,192,800)	57,851)
4.75%	968,700)	46,013)
0.50%	846,700)	4,234)
1.50%	589,800)	8,847)
1.25%	817,700)	10,221)
2.63%	648,200)	17,015)
2.13%	683,900)	14,533)
Total	22,393,700)	784,155)
3.50%

¹ US$ in thousands

² Weighted-average interest rate = 100 × 784,155 ÷ 22,393,700 = 3.50%

Allergan PLC (NYSE:AGN)

Analysis of Debt